Literature DB >> 7535587

Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: requirement for cell-to-cell interactions and colony-stimulating factors.

T A Davis1, D H Robinson, K P Lee, S W Kessler.   

Abstract

Primary autologous as well as allogeneic and xenogeneic stroma will support human stem cell proliferation and differentiation for several months. In the present study, we investigated the capacity of porcine microvascular endothelial cells (PMVECs) together with combinations of cytokines (granulocyte-macrophage colony-stimulating factor [GM-CSF] + stem factor [SCF], interleukin-3 [IL-3] + SCF + IL-6, and GM-CSF + IL-3 + SCF + IL-6) to support the expansion and development of purified human CD34+ bone marrow cells. In short-term cultures (7 days), the greatest expansion of nonadherent hematopoietic cells and clonogenic progenitors was seen with CD34+ cells in direct contact with PMVEC monolayers (PMVEC contact), followed by PMVEC noncontact and liquid suspension cultures, respectively. Maximal expansion of nonadherent cells (42-fold) and total CD34+ cells (12.6-fold) occurred in PMVEC contact cultures treated with GM-CSF + IL-3 + SCF + IL-6, with similar increases in the number of granulocyte-macrophage colony-forming units (CFU-GM), CFU-mix, erythroid burst-forming units (BFU-E), CFU-blast and CFU-megakaryocyte (CFU-Mk) progenitor cells. Moreover, the number of CD34+ CD38- and CD34+ CD38+ cells increased 148.1-fold and 8.0-fold, respectively. Replating studies show that cells from day 7 dispersed blast cell colonies generated on cytokine-treated PMVEC monolayers have a high replating potential for multilineage progenitor cells. In long-term PMVEC contact cultures, CD34+ cells seeded onto PMVEC monolayers with GM-CSF + IL-3 + SCF + IL-6 showed a total calculated expansion of over 5,000,000-fold of nonadherent cells over 35 days in culture. Maximal clonogenic cell production was observed at day 28, with 6,353-fold for total CFC and comparable increases for CFU-GM, CFU-mix, CFU-blast, BFU-E, and CFU-Mk. The total number of CD34+ cells increased 2,584-fold at day 28. Furthermore, the extended growth kinetics of these cultures indicates that these phenotypically primitive progenitor cells are also functionally expanded on PMVEC monolayers. These results support the hypothesis that direct contact with a PMVEC monolayer supports the initial expansion of hematopoietic progenitor cells with a high replating potential and, possibly, a more primitive phenotype (CD34+, CD34+/CD38-).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535587

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

Review 1.  A hostel for the hostile: the bone marrow niche in hematologic neoplasms.

Authors:  Daniela S Krause; David T Scadden
Journal:  Haematologica       Date:  2015-11       Impact factor: 9.941

Review 2.  Stem and progenitor cells in human umbilical cord blood.

Authors:  Myoung Woo Lee; In Keun Jang; Keon Hee Yoo; Ki Woong Sung; Hong Hoe Koo
Journal:  Int J Hematol       Date:  2010-06-25       Impact factor: 2.490

3.  Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells.

Authors:  S N Robinson; J Ng; T Niu; H Yang; J D McMannis; S Karandish; I Kaur; P Fu; M Del Angel; R Messinger; F Flagge; M de Lima; W Decker; D Xing; R Champlin; E J Shpall
Journal:  Bone Marrow Transplant       Date:  2006-02       Impact factor: 5.483

Review 4.  Mesenchymal stem cells in ex vivo cord blood expansion.

Authors:  Simon N Robinson; Paul J Simmons; Hong Yang; Amin M Alousi; J Marcos de Lima; Elizabeth J Shpall
Journal:  Best Pract Res Clin Haematol       Date:  2011-02-23       Impact factor: 3.020

5.  Cord blood-derived hematopoietic stem/progenitor cells: current challenges in engraftment, infection, and ex vivo expansion.

Authors:  Katsuhiro Kita; Jong O Lee; Celeste C Finnerty; David N Herndon
Journal:  Stem Cells Int       Date:  2011-04-27       Impact factor: 5.443

6.  Stimulated stromal cells induce gamma-globin gene expression in erythroid cells via nitric oxide production.

Authors:  Vladan P Cokić; Bojana B Beleslin-Cokić; Reginald D Smith; Antaeus P Economou; Larry M Wahl; Constance T Noguchi; Alan N Schechter
Journal:  Exp Hematol       Date:  2009-07-02       Impact factor: 3.084

7.  Panax ginseng modulates cytokines in bone marrow toxicity and myelopoiesis: ginsenoside Rg1 partially supports myelopoiesis.

Authors:  Hanumantha Rao Balaji Raghavendran; Rekha Sathyanath; Jangwoo Shin; Hyeong Keug Kim; Jong Min Han; JungHyo Cho; Chang Gue Son
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

Review 8.  Exogenous endothelial cells as accelerators of hematopoietic reconstitution.

Authors:  J Christopher Mizer; Thomas E Ichim; Doru T Alexandrescu; Constantin A Dasanu; Famela Ramos; Andrew Turner; Erik J Woods; Vladimir Bogin; Michael P Murphy; David Koos; Amit N Patel
Journal:  J Transl Med       Date:  2012-11-21       Impact factor: 5.531

9.  Production of hemo- and immunoregulatory cytokines by erythroblast antigen+ and glycophorin A+ cells from human bone marrow.

Authors:  Sergey V Sennikov; Tatyana V Injelevskaya; Sergey V Krysov; Alexandr N Silkov; Igor B Kovinev; Natalya J Dyachkova; Anton N Zenkov; Mary I Loseva; Vladimir A Kozlov
Journal:  BMC Cell Biol       Date:  2004-10-18       Impact factor: 4.241

10.  Role of microvascular endothelial cells on proliferation, migration and adhesion of hematopoietic stem cells.

Authors:  Fanli Lin; Shuyue Wang; Hao Xiong; Yang Liu; Xiaoming Li; Chunlan Huang
Journal:  Biosci Rep       Date:  2020-03-27       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.